[Value of medrysone in the treatment of allergic blepharoconjunctivitis in patients with glaucoma treated with epinephrine].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000188:drug therapy*; D004311:Double-Blind Method; D004341:Drug Evaluation; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use*; D005141:Eyelid Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D011282:Pregnenediones / Q000008:administration & dosage / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D011282:Pregnenediones; D004837:Epinephrine
L'intérêt de la médrysone dans le traitement des blépharoconjonctivites allergiques chez les glaucomateux traités à l'épinéphrine.